CAS 111-02-4|Squalene
| Common Name | Squalene | ||
|---|---|---|---|
| CAS Number | 111-02-4 | Molecular Weight | 410.718 |
| Density | 0.8±0.1 g/cm3 | Boiling Point | 429.3±0.0 °C at 760 mmHg |
| Molecular Formula | C30H50 | Melting Point | −75 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 254.1±22.2 °C |
| Symbol | GHS08 | Signal Word | Danger |
Names
| Name | squalene |
|---|---|
| Synonym | More Synonyms |
Squalene BiologicalActivity
| Description | Squalene is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, cardioprotective, antioxidant, and antitoxicant activity. |
|---|---|
| Related Catalog | Research Areas >>Cardiovascular DiseaseResearch Areas >>InfectionNatural Products >>Terpenoids and Glycosides |
| Target | Human Endogenous Metabolite |
| References | [1]. Muzalevskaya EN, et al. SQUALENE: PHYSIOLOGICAL AND PHARMACOLOGICAL PROPERTIES. Eksp Klin Farmakol. 2015;78(6):30-6. |
Chemical & Physical Properties
| Density | 0.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 429.3±0.0 °C at 760 mmHg |
| Melting Point | −75 °C(lit.) |
| Molecular Formula | C30H50 |
| Molecular Weight | 410.718 |
| Flash Point | 254.1±22.2 °C |
| Exact Mass | 410.391266 |
| LogP | 13.09 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.492 |
| InChIKey | YYGNTYWPHWGJRM-AAJYLUCBSA-N |
| SMILES | CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C |
| Storage condition | 2-8°C |
| Water Solubility | <0.1 g/100 mL at 19 ºC |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 5 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JJCREP Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- Volume(issue)/page/year: 76,1021,1985
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1800 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JJCREP Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- Volume(issue)/page/year: 76,1021,1985 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X9556 No. of Facilities: 20 (estimated) No. of Industries: 1 No. of Occupations: 3 No. of Employees: 737 (estimated) No. of Female Employees: 717 (estimated)
Safety Information
| Symbol | GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H304 |
| Precautionary Statements | P301 + P310-P331 |
| Personal Protective Equipment | Eyeshields;Gloves |
| Hazard Codes | F |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | XB6010000 |
| Packaging Group | II; III |
| Hazard Class | 4.1 |
| HS Code | 29012980 |
Customs
| HS Code | 2901299090 |
|---|---|
| Summary | 2901299090 unsaturated acyclic hydrocarbons。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:2.0%。General tariff:30.0% |
Articles122
More Articles| The mannoprotein TIR3 (CAGL0C03872g) is required for sterol uptake in Candida glabrata. Biochim. Biophys. Acta 1851(2) , 141-51, (2015) Sterol uptake in the pathogenic fungus, Candida glabrata, occurs via the sterol transporter, CgAus1p. Azole inhibition of sterol biosynthesis can under certain circumstances be reversed by adding exog... | |
| Comparison of rheological properties, follicular penetration, drug release, and permeation behavior of a novel topical drug delivery system and a conventional cream. Eur. J. Pharm. Biopharm. 88(3) , 614-24, (2015) A novel adapalene-loaded solid lipid microparticle (SLMA) dispersion as a topical drug delivery system (TDDS) for follicular penetration has been introduced. The objective of the present study was to ... | |
| Identification of a novel hypocholesterolemic protein, major royal jelly protein 1, derived from royal jelly. PLoS ONE 9(8) , e105073, (2014) Royal jelly (RJ) intake lowers serum cholesterol levels in animals and humans, but the active component in RJ that lowers serum cholesterol level and its molecular mechanism are unclear. In this study... |
Synonyms
| Squalene, all-trans- |
| (6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene |
| (E,E,E,E)-Squalene |
| 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene |
| (all-E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene |
| Squalene |
| triacontahexaene |
| Spinacen |
| EINECS 203-826-1 |
| Supraene |
| MFCD00008912 |
| 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (6E,10E,14E,18E)- |
| SQUALENE OIL |
| SPINACENE |
| SQUALENE WITH GC |
| (6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene |
| Squalen |
| 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene |
| trans-Spinacene |
